Obesity is a major global health issue, increasing the risk of heart disease, diabetes, and high blood pressure. Despite many ...

Roche (OTCQX:RHHBY) is looking to boost its presence in the booming weight-loss market through an exclusive collaboration and ...

UD researchers discover that differences in gene expression in fat could be the key to targeted obesity treatment. According to the CDC, up to 40% of Americans are obese, increasing their risk of high ...

A team of researchers have made a groundbreaking development related to a protein that is naturally produced in the body but ...

Illegal networks are flooding the market with counterfeit weight loss drugs, posing a serious threat to public health. The ...

In the ever-evolving landscape of healthcare, groundbreaking innovations are not merely celebrated for their scientific ingenuity but for their potential to radically improve human lives. One such ...

Therapeutics aims to improve current obesity treatment, specifically to increase overall body weight loss and fat mass loss, ...

Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...

Experts say incorporating mental health support into obesity care is critical for effective and sustained outcomes. How can ...

Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...

Almost half of women in Africa will be obese or overweight by 2030, according to a new study, an "alarming rise" that has ...

Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...